Polymorphisms of XRCC4 are involved in reduced colorectal cancer risk in Chinese schizophrenia patients

Yang Wang,Lei Wang,Xingwang Li,Baocheng Liu,Qingzhu Zhao,Peng Chen,Ti Wang,Tao Li,Jue Ji,Fengping Yang,Quan Wang,Jinfen Wang,Yanzeng Xiao,Yifeng Xu,Guoyin Feng,Zhihai Peng,Lin He,Guang He
DOI: https://doi.org/10.1186/1471-2407-10-523
IF: 4.638
2010-01-01
BMC Cancer
Abstract:Background Genetic factors related to the regulation of apoptosis in schizophrenia patients may be involved in a reduced vulnerability to cancer. XRCC4 is one of the potential candidate genes associated with schizophrenia which might induce colorectal cancer resistance. Methods To examine the genetic association between colorectal cancer and schizophrenia, we analyzed five SNPs (rs6452526, rs2662238, rs963248, rs35268, rs2386275) covering ~205.7 kb in the region of XRCC4. Results We observed that two of the five genetic polymorphisms showed statistically significant differences between 312 colorectal cancer subjects without schizophrenia and 270 schizophrenia subjects (rs6452536, p = 0.004, OR 0.61, 95% CI 0.44-0.86; rs35268, p = 0.028, OR 1.54, 95% CI 1.05-2.26). Moreover, the haplotype which combined all five markers was the most significant, giving a global p = 0.0005. Conclusions Our data firstly indicate that XRCC4 may be a potential protective gene towards schizophrenia, conferring reduced susceptibility to colorectal cancer in the Han Chinese population.
What problem does this paper attempt to address?